Hemodynamic effects of fluoxetine in pulmonary arterial hypertension: an open label pilot study

Adetoun Sodimu, Sonja Bartolome, Oluwatosin P. Igenoza, Kelly M. Chin

Research output: Contribution to journalArticlepeer-review

Abstract

In order to evaluate the therapeutic potential of fluoxetine in pulmonary arterial hypertension, 13 patients with pulmonary arterial hypertension underwent catheterization before and after 12 (N = 5) or 24 (N = 8) weeks fluoxetine therapy. No change was seen in the primary endpoint of pulmonary vascular resistance, other hemodynamic values, or any secondary endpoints.

Original languageEnglish (US)
JournalPulmonary Circulation
Volume10
Issue number4
DOIs
StatePublished - 2020

Keywords

  • pulmonary hypertension
  • right heart catheterization treatment

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Hemodynamic effects of fluoxetine in pulmonary arterial hypertension: an open label pilot study'. Together they form a unique fingerprint.

Cite this